compound introduction
Montelukast sodium hydrate is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies. It is a subtype specific CysLT1 receptor antagonist.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Montelukast sodium hydrate
CAS number：151767-02-1 molecular formula：C35H35ClNO3S·Na · xH2O
overview
Specs
| Chinese alias | 孟鲁司特钠 水合物 | ||
| English alias | AKOS015994699 | BCP26683 | Singular | sodium 2-[1-({[(1R)-1-{3-[(1E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanyl}methyl)cyclopropyl]acetate | J-522711 | DTXSID8046450 | NSC 759107 | Montelukast sodium- Bio-X | ||
| CAS number | 151767-02-1 | molecular formula | C35H35ClNO3S·Na · xH2O |
| molecular weight | 608.17 (anhydrous ba | Exact mass | ≥99% |
| PSA | 98.600 Ų | logp | - |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
RTECS：
GZ0698000
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 1 shareMSDS
151767-02-1 | Montelukast Sodium.pdf
